학술논문

Alternating short-course oxaliplatin-based chemotherapy and nivolumab as first-line treatment of patients with abdominal metastases from microsatellite-stable (MSS) colorectal cancer (CRC): A randomized phase 2 trial.
Document Type
Article
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3552-3552, 1p
Subject
Language
ISSN
0732183X